Walgreens Boots Alliance, Inc. (WBA) Total Return:31.43%(TTM)
Over the latest trailing 12-month period, Walgreens Boots Alliance, Inc. (WBA)'s total return cagr is +31.43%. The comparable SPY value is +24.27%. Year-to-date total return is +28.40%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in WBA
$26,497
(2.6x return)
Invested on Jun 13, 1996
Growth of $10,000 in SPY (S&P 500)
$160,753
(16.1x return)
Invested on Jun 13, 1996
Hypothetical Growth of $10,000
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
Recent Performance Indicators
YTD Total Return
+28.4%
1-Year Total Return
+31.4%
Current Dividend Yield
0.00%
Price CAGR vs. Total Return CAGR
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +27.7% | +31.4% | +3.7% |
| 3 Years | (30.6%) | (26.9%) | +3.8% |
| 5 Years | (20.9%) | (17.0%) | +3.9% |
| 10 Years | (18.0%) | (14.9%) | +3.1% |
| 15 Years | (5.3%) | (2.3%) | +3.1% |
| 20 Years | (6.5%) | (4.0%) | +2.6% |
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth